Detalhe da pesquisa
1.
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
Nephrol Dial Transplant
; 25(1): 129-36, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19666912
2.
Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
Am J Kidney Dis
; 50(2): 248-56, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17660026
3.
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
Am J Kidney Dis
; 46(6): 1012-29, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16310567
4.
Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
Nephrol Dial Transplant
; 21(2): 389-96, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16234291
5.
Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study.
J Am Soc Nephrol
; 16(1): 169-74, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15563570
6.
Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
Nephrol Dial Transplant
; 19(5): 1142-8, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-14993502
7.
Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
Nephrol Dial Transplant
; 19(8): 2036-43, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15187191